Does gestational diabetes affect the therapeutic potential of umbilical cord-derived stem cells?

Multipotent cells isolated from the human umbilical cord, called mesenchymal stromal cells have shown promise for use in cell therapy to treat a variety of human diseases. However, intriguing new evidence shows that hUC-MSCs isolated from women with gestational diabetes demonstrate premature aging, poorer cell growth, and altered metabolic function, as reported in an article in Stem Cells and Development , a peer-reviewed journal from Mary Ann Liebert, Inc., publishers .

http://ift.tt/1KYfdsY